Search academic texts

Information × Registration Number 0308U001627, 0106U003513 , R & D reports Title A Muiticenter, Randomized, Double-Blind Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer. popup.stage_title Дослідження ефективності та систематизація інформації щодо ефективності Дарбопоетину Альфа при лікуванні анемії ракового захворювання. Head Hotko Evgen Stepanovych, Registration Date 13-02-2008 Organization Uzhgorod National University popup.description2 By results of the work it is shown that using of darbepoetin alpha for long-term use for treating anemia in patients with malignancy is inexpedient. In spite of highest quality of life of patients in study drug group, survival of patients in placebo group is highest than patients in group of study drug.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close